Biogen (BIIB) Reports Significant Data from BG-12 Phase 3 in Treating MS
Go back to Biogen (BIIB) Reports Significant Data from BG-12 Phase 3 in Treating MS| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 217.59 +3.24 (1.51%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $214.35 | 52 Week High | $333.65 | |||
| Open | $217.76 | 52 Week Low | $223.02 | |||
| Day High | $219.12 | P/E | 27.86 | |||
| Day Low | $215.00 | EPS | $7.81 | |||
| Volume | 319,134 | |||||
